Monday, May 26 is Memorial Day. Our lab and all support services will be closed. Kit orders placed on May 26 will be sent on May 27, and all in-transit patient samples will be held by the carrier and received on May 27. If you need assistance, please leave a message at 888-729-1206 or support@genedx.com and we will respond when we return on May 27.
We accept all commercial insurance, Medicaid, Medicare, and Tricare plans (see them here). We also offer competitive self-pay pricing, interest free payment plans and, for eligible patients, a Financial Assistance Program.
Your healthcare provider will place the test order and GeneDx will likely request a prior authorization (PA) approval from your insurance company, unless it is not required. Even though GeneDx is in-network with many commercial health plans, PAs are often required for many genetic tests.
Your provider may perform a benefits investigation (BI). The purpose of a BI is to calculate what you may expect to pay out-of-pocket. It’s important to remember that this is strictly an estimate and is subject to change based on various factors, including the status of the prior authorization.
Your final out-of-pocket cost for genetic testing is based on many factors, including the type of test ordered and your health insurance plan, which determines your copay, coinsurance, and deductible.
Insurance carriers increasingly cover genetic testing. But even if your test is covered, you may still receive a bill for testing if you have not yet met your yearly plan deductible. Like any other medical testing or care, many plans require that you meet your deductible before they cover the cost of genetic testing.
If you have any questions or feel your final bill may need to be revised, please get in touch with our billing team at billing@genedx.com.
At GeneDx, we firmly believe that everyone deserves access to vital insights from genetic testing, regardless of their financial situation. We offer a robust Financial Assistance Program to help reduce the potential out-of-pocket costs associated with testing.
The program has broad eligibility criteria, meaning that most patients will qualify for some level of financial assistance.
